about
Cytokinome profile evaluation in patients with hepatitis C virus infectionCytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infectionVitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell linesThe Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesComparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell linesCarotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver DiseaseIs serum Interleukin-17 associated with early atherosclerosis in obese patients?Assessment of the Selenoprotein M (SELM) over-expression on human hepatocellular carcinoma tissues by immunohistochemistry.Anti-Inflammatory Effects of a Methanol Extract from the Marine Sponge Geodia cydonium on the Human Breast Cancer MCF-7 Cell Line.GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissuesAcquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based ImmunoassaysAscorbic acid: its role in immune system and chronic inflammation diseases.Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines.Potential Anticancer Effects of Polyphenols from Chestnut Shell Extracts: Modulation of Cell Growth, and Cytokinomic and Metabolomic Profiles.Differential Response of Two Human Breast Cancer Cell Lines to the Phenolic Extract from Flaxseed Oil.Potential anti-inflammatory effects of the hydrophilic fraction of pomegranate (Punica granatum L.) seed oil on breast cancer cell lines.Dissimilar cytokine patterns in different human liver and colon cancer cell lines.Evaluation of selenite effects on selenoproteins and cytokinome in human hepatoma cell lines.Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma.Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients.Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis.Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma.Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.Serum cytokine levels in patients with hepatocellular carcinoma.Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.Evaluating the Effects of an Organic Extract from the Mediterranean Sponge Geodia cydonium on Human Breast Cancer Cell Lines.Correction: Metabolomic profiling and biochemical evaluation of the follicular fluid of endometriosis patients.Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines.Phytochemical profile of Juniperus oxycedrus ssp. oxycedrus berries: A new monoterpene glucoside and evaluation of the effects on cancer cell linesEffects of Lipoic Acid, Caffeic Acid and a Synthesized Lipoyl-Caffeic Conjugate on Human Hepatoma Cell LinesAn approach for understanding the inflammation and cancer relationshipSimultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's diseaseReprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanomaEffects of α-zearalenol on the metabolome of two breast cancer cell lines by 1H-NMR approach
P50
Q26849696-81CB8FCE-C3A9-4C7C-8B5A-0FDB9834D280Q28480545-6E1BFC47-7316-4B19-88C8-1EFE658195F7Q28542814-8FDCCBAC-4AC0-4DE8-9CDD-5142F6369E19Q28546913-25510A84-B9FE-41D9-B441-B2F404FDEC74Q33599250-D0C32180-79AE-4A41-92F4-AD1CEF28390BQ34275915-06E082EA-883C-49C3-B63F-01A0C7DBC0CCQ34635257-10A53539-7B1A-4588-8A27-1B07E45EC730Q34905419-A0DAA130-8680-4C66-9057-D3072A66C789Q36145053-A9F68696-3AF9-40AC-A9AD-7040986C2AD3Q36423077-38B38230-FAC9-4F5F-8E3D-8AFBB1E45324Q36907149-A7704D85-D59B-450F-BD73-CDE377923B3CQ37516483-7E685BD0-BAFC-4580-81A8-BDC1CD63D876Q38207124-A2FFC0A1-D29F-410A-BB99-157055489C6CQ38720621-71827071-DA3D-4BE4-90D5-494EDD46A09FQ38738042-F108CBBA-D174-49F6-B11B-1106A5622F19Q38784007-8860BB27-DA4D-42EB-96CD-DB6332C4818FQ38981529-353509CB-AEB7-41D1-9D6F-F6F3C30343B3Q39092340-95F5E30E-A867-452E-BCB1-D2A2C73E68E2Q39188309-F9A58A77-FC63-414E-96D1-EE3D216F43BAQ42691470-4A3926FB-EA6F-49F5-AE19-122CD13C899DQ42978008-19D55ED2-E67D-49D7-B268-866A28EDB9B9Q43001543-8813CD3C-DE7A-43BB-A2EA-AB95C81971E5Q45099106-114D076D-F8D2-4282-B929-EF28D4FA1B03Q46629247-61A27C03-E76E-494D-88A5-DB124F24552DQ46745912-703DFDC7-46E0-4428-9EB7-0E63097B0F75Q47104348-EBE50769-72B2-4241-BA54-FE479D530CF3Q47117826-0E680E78-827D-419E-B819-0DFC79E0096CQ48603265-A8900D32-38D7-4352-A789-50A017C13806Q50909597-BEC8DC42-C231-4CF8-9452-56C0472B8925Q51284365-6B927BD1-AE82-4DD1-8551-3E216E2FA57EQ59210144-E0093823-22CD-41F7-ABD2-57B2E55EBF56Q59210247-ACADF8E6-A86E-48E5-92A2-E194C46ABA29Q59210324-37D114AE-868A-4A9B-BE34-645F8243B656Q82950382-1EF3D74B-1ECC-44AC-A3D5-46F70D309D17Q91738301-C20A868F-AFFD-4CCD-AAFE-C80EAB557EB6Q92105034-50E5DFDB-011C-4AEB-8260-24DE8C8C8440
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Capone
@ast
Francesca Capone
@en
Francesca Capone
@es
Francesca Capone
@nl
type
label
Francesca Capone
@ast
Francesca Capone
@en
Francesca Capone
@es
Francesca Capone
@nl
prefLabel
Francesca Capone
@ast
Francesca Capone
@en
Francesca Capone
@es
Francesca Capone
@nl
P106
P1153
7003677271
P21
P31
P496
0000-0002-5402-6228